Financials Touyun Biotech Group Limited

Equities

1332

BMG8962M1038

Non-Paper Containers & Packaging

Market Closed - Hong Kong S.E. 04:08:06 2024-04-30 am EDT 5-day change 1st Jan Change
0.23 HKD 0.00% Intraday chart for Touyun Biotech Group Limited +53.33% 0.00%

Valuation

Fiscal Period: December 2017 2018 2019 2020 2021 2022
Capitalization 1 2,694 1,323 551.1 2,080 3,704 1,207
Enterprise Value (EV) 1 2,626 1,415 606.3 2,140 4,015 1,558
P/E ratio -11 x -5.21 x -2.75 x -11.9 x -50.6 x -6.09 x
Yield - - - - - -
Capitalization / Revenue 8.48 x 3.79 x 1.61 x 10.1 x 13.1 x 3.82 x
EV / Revenue 8.27 x 4.06 x 1.77 x 10.3 x 14.2 x 4.93 x
EV / EBITDA -21 x -11.4 x -21.2 x -42.8 x -117 x -51.5 x
EV / FCF -92.6 x -5.08 x 4.58 x -11.8 x -45.1 x -39.1 x
FCF Yield -1.08% -19.7% 21.8% -8.47% -2.22% -2.56%
Price to Book 2.81 x 1.82 x 1.02 x 4.26 x 7.88 x 4.57 x
Nbr of stocks (in thousands) 2,449,328 2,449,328 2,449,328 2,773,652 2,805,952 2,805,952
Reference price 2 1.100 0.5400 0.2250 0.7500 1.320 0.4300
Announcement Date 4/24/18 4/18/19 4/28/20 4/13/21 4/28/22 4/27/23
1HKD in Million2HKD
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2017 2018 2019 2020 2021 2022
Net sales 1 317.7 348.8 342.7 206.8 283.5 315.8
EBITDA 1 -125.2 -123.6 -28.64 -49.94 -34.44 -30.24
EBIT 1 -134.6 -144.7 -36.24 -54.86 -38.15 -42.46
Operating Margin -42.38% -41.48% -10.57% -26.53% -13.46% -13.45%
Earnings before Tax (EBT) 1 -249 -252 -194.9 -172 -123 -199.2
Net income 1 -245.2 -253.9 -200.5 -168.8 -72.95 -198.1
Net margin -77.19% -72.79% -58.51% -81.62% -25.73% -62.71%
EPS 2 -0.1001 -0.1037 -0.0819 -0.0632 -0.0261 -0.0706
Free Cash Flow 1 -28.35 -278.7 132.3 -181.1 -89.05 -39.85
FCF margin -8.92% -79.92% 38.62% -87.59% -31.41% -12.62%
FCF Conversion (EBITDA) - - - - - -
FCF Conversion (Net income) - - - - - -
Dividend per Share - - - - - -
Announcement Date 4/24/18 4/18/19 4/28/20 4/13/21 4/28/22 4/27/23
1HKD in Million2HKD
Estimates

Balance Sheet Analysis

Fiscal Period: December 2017 2018 2019 2020 2021 2022
Net Debt 1 - 92 55.2 59.3 312 351
Net Cash position 1 68.3 - - - - -
Leverage (Debt/EBITDA) - -0.7443 x -1.926 x -1.187 x -9.045 x -11.61 x
Free Cash Flow 1 -28.4 -279 132 -181 -89 -39.8
ROE (net income / shareholders' equity) -23.5% -30.1% -31.3% -31.2% -23.8% -52.6%
ROA (Net income/ Total Assets) -6.43% -7.56% -2.35% -3.69% -2.39% -2.78%
Assets 1 3,811 3,358 8,544 4,574 3,054 7,136
Book Value Per Share 2 0.3900 0.3000 0.2200 0.1800 0.1700 0.0900
Cash Flow per Share 2 0.1400 0.0400 0.0200 0.0500 0.0200 0.0500
Capex 1 38.6 27.4 3.66 126 164 12.9
Capex / Sales 12.15% 7.84% 1.07% 60.7% 57.67% 4.09%
Announcement Date 4/24/18 4/18/19 4/28/20 4/13/21 4/28/22 4/27/23
1HKD in Million2HKD
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Change in Enterprise Value/EBITDA

  1. Stock Market
  2. Equities
  3. 1332 Stock
  4. Financials Touyun Biotech Group Limited